medigraphic.com
SPANISH

Revista Latinoamericana de Infectología Pediátrica

ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 4

<< Back Next >>

Rev Latin Infect Pediatr 2024; 37 (4)

Clinical manifestations and laboratory findings in pediatric patients with presumptive diagnosis of dengue virus infection in a second level hospital in Irapuato: case series

Reyes BML, Contreras VLM, Rojas SMB, Aguilera SM, Olmos PMLE
Full text How to cite this article 10.35366/118315

DOI

DOI: 10.35366/118315
URL: https://dx.doi.org/10.35366/118315

Language: Spanish
References: 17
Page: 156-162
PDF size: 327.16 Kb.


Key words:

dengue, National Committee for Epidemiological Surveillance, World Health Organization, Pan American Health Organization.

ABSTRACT

Introduction: viral disease transmitted by mosquitoes of the genus Aedes, one of the most significant public health problems worldwide. Objective: to describe clinical and laboratory data in pediatric patients at HGZ/MF No. 2, Instituto Mexicano del Seguro Social (IMSS), Irapuato, Guanajuato, who met one of the operational definitions of dengue. Our next objective was to analyze the administrative process for compliance with the epidemiological surveillance (EV) established by the National Committee for Epidemiological Surveillance (CONAVE). Material and methods: descriptive, cross-sectional study in pediatric patients aged 3 to 17 years, clinically diagnosed with dengue, between October 1, 2023 and November 30, 2023. Results: 22 patients, 12 males (54.5%), and 10 (45.5%) females. Sixteen of the cases (72.7%) presented in the month of November. Alarm data; were continuous severe abdominal pain (81%), and persistent vomiting (68%). 18 patients were admitted with (DCSA) dengue with alarm signs (81.8%). 12 (54.5%) cases presented severe thrombocytopenia. Two patients presented pleural effusion (9%) and one of them was associated with ascites. 18 children (81.8%) presented increased liver enzymes. Two patients (9%) met the operational definition of severe dengue (GD). We confirmed 13 (59%) patients by RT-PCR (polymerase chain reaction), of which 8 (61.5%) were dengue non serious (DNV) serotype 3, and 5 positive (38.5%) without serotype report. One negative PCR of a patient who complied with the operational definition, however the RT-PCR was taken after day seven of evolution of the current illness, had positive serology for dengue (IgM). We had three samples rejected due to lack of compliance in the quality of these samples. During the hospital care process between the emergency department, nursing, pediatric hospitalization and laboratory, five samples were not sent. Conclusion: we had problems in the administrative process of the epidemiological surveillance, so we reflect on how to improve it. This is the first year in the history of our hospital (inaugurated in 1975) that we have this epidemiological situation of dengue. We reported one death.


REFERENCES

  1. CENETEC. Clasificación, diagnóstico y tratamiento integral del dengue. Resumen de evidencias y recomendaciones: Guía de Práctica clínica. 2016.

  2. CONAVE; Aviso epidemiológico. 2023.

  3. Wong JM, Adams LE, Durbin AP et al. Dengue: a growing problem with new interventions. Pediatrics. 2022; 149 (6): e2021055522.

  4. Pavlicich V. Dengue: revisión y experiencia en pediatría. Arch Pediatr Urug. 2016; 87 (2): 143-156.

  5. Tafani R, Chiesa G, Caminati R, Gaspio N. Factores de riesgo y determinantes de la salud. Factores riesgo y Determ la salud. 2013; 17 (3): 53-68.

  6. Dehesa LE, Gutiérrez AAF. Dengue: actualidades y características epidemiológicas en México. Rev Med UAS. 2019; 9 (3): 159-170.

  7. Thomas SJ, Rothman AL, Srikiatkhachorn A, Kalayanarooj S. Dengue virus infection: clinical manifestations and diagnosis. UptoDate; 2023.

  8. Cobra C, Rigau JG, Kuno G, Vorndam V. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico 1990-1991. Am J Epidemiol. 1995; 142 (11): 1204-1211.

  9. Alvarado, M; Ramírez, E; Paredes, S. et al. Caracterización clínica del dengue y variables predictoras de gravedad en pacientes pediátricos en un hospital de segundo nivel en Chilpancingo, Guerrero, México: serie de casos. Bol Med Hosp Infant Mex. 2016; 73 (4): 237-242.

  10. Cao XT, Ngo TN, Wills B et al. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop Med Int Health. 2002; 7 (2): 125-132.

  11. Tayal A, Kabra SK, Lodha R. Management of dengue: an updated review. Indian J Pediatr. 2023; 90 (2): 168-177.

  12. Guzman MG, Harris E. Dengue. Lancet. 2015; 385 (9966): 453-465.

  13. Huits R, Soentjens P, Maniewski-Kelner U et al. Clinical utility of the nonstructural 1 antigen rapid diagnostic test in the management of dengue in returning travelers with fever. Open Forum Infect Dis. 2017; 4 (1): ofw273.

  14. Hunsperger EA, Muñoz-Jordán J, Beltrán M et al. Performance of dengue diagnostic tests in a single-specimen diagnostic algorithm. J Infect Dis. 2016; 214 (6): 836-844.

  15. Rodríguez-Salazar CA, Recalde-Reyesa DP, González MM et al. Manifestaciones clínicas y hallazgos de laboratorio de una serie de casos febriles agudos con diagnóstico presuntivo de infección por el virus dengue. Quindío (Colombia). Infectio. 2016; 20 (2): 84-92.

  16. OPS. Dengue y dengue hemorrágico en las Américas. Guías para su prevención y control. 1995.

  17. Vargas NA, Bustos VE, Salas CA et al. Infección por dengue, un problema de salud pública en México. JONNPR. 2021; 6 (2): 293-306.




Figure 1
Figure 2
Table 1
Table 2
Table 3
Table 4
Table 5

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Latin Infect Pediatr. 2024;37